![Icon depicting a video play button](https://biologics.catalent.com/wp-content/uploads/sites/2/2023/03/video.png)
Catalent’s iPSCs as a Starting Material for Advanced Cell Therapies
Summary: iPSCs are a critical starting material for advanced cell therapies. Learn more about Catalent’s GMP iPSC capabilities including reprogramming, differentiation, and cell banking, and how they can advance cell therapies to clinic.